Authors

Drs. Anne E. Winkler and Kristi V. Mizelle discuss the negative long term disease outcomes noted in patients who experience a delay in their lupus diagnosis.

Kristin Setmour

Kristine Lohr MD

Kristine Lohr, M.D.

Kyle Cassas, MD

Laird Harrison

Possible Mechanism and Treatment for Fibromyalgia Reported

5 years ago

Lysophosphatidylcholine 16:0 (LPC16:0), an oxidized lipid, may mediate the pain that people with fibromyalgia experience, according to researchers writing in the Annals of the Rheumatic Diseases.

Larry Byrd MD

Larry W. Moreland, MD

Authors

Impact of Diagnosis Delay on Long Term Lupus Outcomes

Possible Mechanism and Treatment for Fibromyalgia Reported

Trending on HCPLive

Updated ACC/AHA Dyslipidemia Guidelines Incorporate LDL-C Goals, Lp(a) Focus, With Deepak Bhatt, MD, MPH

Tegoprubart Improves Glycemic Control Following Islet Transplantation for T1D, With Piotr Witkowski, MD, PhD

Stratifying Risk, Optimizing Therapy in IgA Nephropathy, With Abdallah Geara, MD

Diagnosing Iron Deficiency Anemia — Ferritin Thresholds, Confirmatory Testing, and Workup

IgG Reactivity Patterns in Pediatric Food Allergy, With Julia Angkeow